Caregivers already dealing with the stress of looking after a loved one diagnosed with Parkinson's disease often have another concern to contend with—aggressive behavior directed toward them from the Parkinson's patient.
Nov 7, 2022
0
20
African American men tend to be diagnosed more frequently with prostate cancer and have higher mortality rates than men of other races and ethnicities. Despite this substantial cancer disparity, few prospective studies focused ...
Sep 21, 2022
0
14
A study led by researchers from The University of Texas MD Anderson Cancer Center found a significant association between cholesterol-lowering drugs commonly known as statins and survival rates of triple-negative breast cancer ...
Aug 3, 2021
0
65
New prostate cancer urine test shows how aggressive disease is and could reduce invasive biopsies
Apr 27, 2021
0
73
A new study shows more aggressive treatment may be needed for a large number of patients taking statin medications, and that treatment could help reduce cases of cardiovascular disease, the leading cause of death in the U.S.
May 9, 2019
0
0
For about 90 percent of men with prostate cancer, the cancer remains localized to the primary site, resulting in a five-year survival rate of almost 100 percent. Unfortunately, the remaining 10 percent of patients develop ...
May 9, 2019
0
84
Researchers at Lund University in Sweden have together with American colleagues studied deceased patients who were diagnosed with Alzheimer's disease or frontotemporal dementia. They observed a correlation between certain ...
Apr 15, 2019
0
7
Differences in the abundance of certain bacteria living on the tongue can distinguish patients with early pancreatic cancers from healthy individuals, according to results from a new study published in the Journal of Oral ...
Jan 28, 2019
0
7
Working with researchers from Stanford University and St. Anna Children's Cancer Research, researchers from Jürgen Pollheimer's laboratory at the Medical University of Vienna's Department of Obstetrics and Gynecology have ...
Oct 15, 2018
0
88
(HealthDay)—The U.S. Food and Drug Administration says it has expanded approval for Blincyto (blinatumomab) to include adults and children with B-cell precursor acute lymphoblastic leukemia who are in remission but who ...
Mar 30, 2018
0
1
